Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02516813
Title Phase 1 Trial of MSC2490484A, an Inhibitor of a DNA-dependent Protein Kinase, in Combination With Radiotherapy
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors EMD Serono
Indications

lung non-small cell carcinoma

Advanced Solid Tumor

lymphoma

Therapies

Peposertib

Age Groups: adult
Covered Countries USA | DEU | BEL


No variant requirements are available.